Enhanced Osteopontin Expression and Macrophage Infiltration in MRL-Fas^lpr Mice with Lupus Nephritis

References

• Butler W. T. The nature and significance of osteopontin. Connect. Tissue Res. 1989; 23: 123–36
   PubMed Web of Science ®Google Scholar
• Denhardt D. T., Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993; 7: 1475–82
   PubMed Web of Science ®Google Scholar
• Brown L. F., Berse B., Van de Water L., et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 1992; 3: 1169–80
   PubMed Web of Science ®Google Scholar
• Lopez C. A., Hoyer J. R., Wilson P. D., Waterhouse P., Denhardt D. T. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab. Invest. 1993; 69: 355–63
   PubMedGoogle Scholar
• Kleinman J. G., Beshensky A., Worcester E. M., Brown D. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int. 1995; 47: 1585–96
   PubMedGoogle Scholar
• Madsen K. M., Zhang L., Shamat A. A., Siegfried S., Cha J. -H. Ultrastructural localization of osteopontin in the kidney: induction by lipopolysaccharide. J. Am. Soc. Nephrol. 1997; 8: 1043–53
   PubMedGoogle Scholar
• Kohri K., Nomura S., Kitamura Y., et al. Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J. Biol. Chem. 1993; 268: 15180–4
   PubMed Web of Science ®Google Scholar
• Hoyer J. R. Uropontin in urinary calcium stone formation. Miner. Electrolyte Melab. 1994; 20: 385–92
   PubMedGoogle Scholar
• Singh R. P., Patarca R., Schwartz J., Singh P., Cantor H. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effects upon macrophages in vivo. J. Exp. Med. 1990; 171: 1931–42
   PubMed Web of Science ®Google Scholar
• Yamamoto S., Nasu K., Ishida T., et al. Effect of recombinant osteopontin on adhesion and migration of P388D1 cells. Ann. N. Y. Acad. Sci. 1995; 760: 378–80
   PubMedGoogle Scholar
• Liaw L., Almeida M., Hart C. E., Schwartz S. M., Giachelli C M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 1994; 74: 214–24
   PubMed Web of Science ®Google Scholar
• Pichler R., Giachelli C M., Lombardi D., et al. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am. J. Pathol. 1994; 144: 915–26
   PubMed Web of Science ®Google Scholar
• Giachelli C M., Pichler R., Lombardi D., et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 1994; 45: 515–24
   PubMedGoogle Scholar
• Eddy A. A., Giachelli C M. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int. 1995; 47: 1546–57
   PubMed Web of Science ®Google Scholar
• Boswell J. M., Yui M. A., Burt D. W., Kelley V. E. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 1988; 141: 3050–4
   PubMed Web of Science ®Google Scholar
• Fan X., Wüthrich R. P. Upregulation of lymphoid and renal interferon-γ mRNA in autoimmune MRh-Faslpr mice with lupus nephritis. Inflammation 1997; 21: 109–18
   Google Scholar
• Lemay S., Mao C., Singh A. K. Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney Int. 1996; 50: 85–93
   PubMedGoogle Scholar
• Wiithrich R. P., Jevnikar A. M., Takei F., Glimcher L. H., Kelley V. E. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am. J. Pathol. 1990; 136: 441–50
   PubMedGoogle Scholar
• Wüthrich R. P. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 1992; 42: 903–14
   PubMed Web of Science ®Google Scholar
• Worcester E. M., Blumenthal S. S., Beshensky A. M., Lewand D. L. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J. Bone Miner. Res. 1992; 7: 1029–36
   PubMed Web of Science ®Google Scholar
• McKnight A. J., Macfarlane A. J., Dri P., Turley L., Willis A. C., Gordon S. Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J. Biol. Chem. 1996; 271: 486–9
   PubMed Web of Science ®Google Scholar
• Craig A. M., Smith J. H., Denhardt D. T. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J. Biol. Chem. 1989; 264: 9682–9
   PubMed Web of Science ®Google Scholar
• Benz P. S., Fan X. H., Wüthrich R. P. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney Int. 1996; 50: 156–63
   PubMed Web of Science ®Google Scholar
• Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–9
   PubMed Web of Science ®Google Scholar
• Haverty T. P., Kelly C. J., Hines W. H., et al. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 1988; 107: 1359–68
   PubMed Web of Science ®Google Scholar
• Patarca R., Saavedra R. A., Cantor H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1 /osteopontin gene. Critical Rev. Immunol. 1993; 13: 225–46
   PubMed Web of Science ®Google Scholar
• Cantor H. The role of Eta-1/osteopontin in the pathogenesis of immunological disorders. Ann. N. Y. Acad. Sci. 1995; 760: 143–50
   PubMedGoogle Scholar
• Patarca R., Freeman G. J., Singh R. P., et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 1989; 170: 145–61
   PubMed Web of Science ®Google Scholar
• Ono M., Yamamoto T., Nose M. Allelic difference in the nucleotide sequence of the Eta-1/Op gene transcript. Mol. Immunol. 1995; 32: 447–8
   PubMedGoogle Scholar
• Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 1978; 148: 1198–215
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A. N., Prud'homme G. J., Dixon F. J. Autoimmune aspects of systemic lupus erythematosus. Concepts Immunopathol. 1985; 1: 190–218
   PubMedGoogle Scholar
• Kelley V. E., Roths J. B. Increase in macrophage la expression in autoimmune mice: role of the lpr gene. J. Immunol. 1982; 129: 923–5
   PubMedGoogle Scholar
• Bloom R. D., Florquin S., Singer G. G., Brennan D. C, Kelley V. R. Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int. 1993; 43: 1000–9
   PubMedGoogle Scholar
• Pichler R. H., Franceschini N., Young B. A., et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J. Am. Soc. Nephrol. 1995; 6: 1186–96
   PubMed Web of Science ®Google Scholar
• Young B. A., Burdmann E. A., Johnson R. J., et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int. 1995; 48: 439–48
   PubMed Web of Science ®Google Scholar
• Watson M. L., Rao J. K., Gilkeson G. S., et al. Genetic analysis of MRL-lpr- mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 1992; 176: 1645–56
   PubMed Web of Science ®Google Scholar
• Shirai A., Klinman D. M. The genetic basis of autoimmune disease in MRL-lpr/lpr mice. Int. Rev. Immunol. 1994; 11: 179–92
   PubMedGoogle Scholar
• Patarca R., Wei F. Y., Singh P., Morasso M. I., Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4--8-lymphocytes during the development of murine autoimmune disease. J. Exp. Med. 1990; 172: 1177–83
   PubMed Web of Science ®Google Scholar
• Lampe M. A., Patarca R., Iregui M. V., Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J. Immunol. 1991; 147: 2902–6
   PubMedGoogle Scholar
• Yokoyama H., Kreft B., Kelley V. R. Biphasic increase in circulating and renal TNF-rv in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 1995; 47: 122–30
   PubMed Web of Science ®Google Scholar